Showing results (901-910 of 1,273) with videos related to
Sort By:
Pageof 128
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 2017
Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION studyGiancarlo Comi, Nicola De Stefano, Mark S Freedman, et al.The Lancet. Neurology|February 8, 2014
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trialThomas P Leist, Giancarlo Comi, Bruce A C Cree, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGADDalia L Rotstein, Mark S Freedman, Andrea Konig, et al.The American Journal of Clinical Nutrition|September 4, 2024
The carbon isotope ratio of breath is elevated by short-term and long-term added sugar and animal protein intake in a controlled feeding studyDiane M O'Brien, Laurence S Freedman, Patricia Rivera, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12Bohuslav Melichar, Renato Lenzi, Michael Rosenblum, et al.Blood|February 1, 1992
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusionM L Grossbard, A S Freedman, J Ritz, et al.Gynecologic Oncology|July 1, 1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancerJ J Kavanagh, C L Edwards, R S Freedman, et al.MMWR. Morbidity and Mortality Weekly Report|March 11, 2021
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020Lyudmyla Kompaniyets, Alyson B Goodman, Brook Belay, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2017
The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studiesMark S Freedman, Jerry S Wolinsky, Giancarlo Comi, et al.Kidney International|March 28, 2018
Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracingDiana G Eng, Natalya V Kaverina, Remington R S Schneider, et al.Pageof 128